Can You Take Wegovy for Just One Month?

Why one month falls before Wegovy even gets started

The STEP 1 trial (published in the New England Journal of Medicine and the key evidence behind Wegovy's UK licence) randomised adults with obesity across 68 weeks. Week four is when participants were still on the 0.25 mg starting dose, which exists to ease your body into the medicine rather than to drive weight loss. The therapeutic doses (1.7 mg and 2.4 mg) are not reached until month four or five at the earliest, depending on how each person tolerates the titration steps.

This matters because a common misconception is that Wegovy works like a crash diet: take it, lose weight fast, stop. It does not. Appetite regulation changes gradually as semaglutide builds in your system. By month one most people notice some reduction in hunger, but measurable weight reduction on the scales is usually modest at that stage.

The practical upshot: if your goal is to lose weight and keep it off, one month is not a meaningful trial of Wegovy, it is the warm-up. Prescribers generally discuss treatment duration in terms of months to years, not weeks. You can read more about what ongoing treatment typically looks like on the Wegovy treatment overview.

What happens when you stop after a short course

Evidence from the STEP 1 extension study and subsequent research is unambiguous: weight regain begins quickly after stopping semaglutide. Within a year of stopping, most participants had regained a substantial proportion of the weight they had lost, even those who had completed the full 68-week course.

Stopping after one month, before meaningful loss has occurred, does not trigger the same scale of regain simply because there is less to regain. But it does mean the treatment has not had enough time to work, and any benefit to appetite patterns or metabolic markers is reversed as the medicine clears.

This is not a reason to feel locked in. If side effects are the concern, there are clinical options, dose adjustment, a slower titration, supportive advice. Our frequently asked questions cover the most common reasons people consider stopping early and what the alternatives tend to be.

Wegovy is a prescription-only medicine, and a GPhC-registered prescriber reviews your situation individually. Stopping is always your choice; the clinical conversation is about making sure that choice is informed.

What NICE guidance actually says about duration and review points

For Wegovy, NICE's appraisal (TA875) sets a review trigger at six months: if less than 5% of body weight has been lost by that point on the maintenance dose, continuing treatment should be reconsidered. That six-month mark is the earliest meaningful assessment point in the guidance. One month is not mentioned as a review point because, clinically, it is not one.

NICE also specifies that Wegovy should be used for a maximum of two years under the NHS pathway, within a specialist weight management service. Private prescribing operates under the licensed indications in the SmPC, which does not cap duration in the same way but does expect ongoing clinical review, which is why every repeat at nume is individually assessed rather than automatically renewed.

If you are thinking about a short course because of cost, it is worth reading about what a three-month course looks like in practice, including where you would be in the titration schedule by that point. Three months begins to approach the range where some people see their first meaningful results, which is different territory from one month. Some people also ask whether taking Wegovy for one month specifically is clinically worthwhile, and the short answer is that a single month sits entirely within the start-up phase, before the medicine has had a real chance to work. Others wonder about taking Wegovy once a month rather than weekly, which reflects a separate misunderstanding of how the dosing schedule is designed.

BMI and weight-related conditions also determine whether you are eligible in the first place. The BMI eligibility guide for Wegovy explains the licensed thresholds in detail.

Making the decision about how long to commit

The honest answer to whether you can take Wegovy for just one month is: yes, legally and practically, you can. The medicine requires a prescription, which requires clinical assessment, but there is no minimum-commitment rule. What there is, is evidence that one month is not long enough for the treatment to demonstrate whether it works for you.

Most people considering a short course are either uncertain about committing to ongoing costs, cautious about side effects, or testing the water before deciding. All of those are reasonable positions. The right place to explore them is with a prescriber who knows your health picture, not a one-size FAQ.

If you would like to understand the full eligibility criteria before starting, the overview of who Wegovy is suitable for is a good starting point. And if costs are part of your thinking, treatment pricing at nume is shown clearly on the treatment page, with no subscription or automatic renewal. Every repeat order is reviewed by a prescriber before it goes anywhere.

Speak to our prescribers if you want a straight answer about whether Wegovy is the right fit for your situation, and what a realistic treatment timeline looks like for you specifically.